跳至主要内容
临床试验/NCT07500376
NCT07500376招募中不适用

Prognostic Value of Multimodal Nutritional Status and Sarcopenia Assessment for Postoperative Risk Stratification in Patients Undergoing Lung Cancer Surgery: A Prospective Cohort Study

Ondokuz Mayıs University1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2026年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
142
试验地点
1
主要终点
Postoperative complications (30-day, Clavien-Dindo classification)

研究概览

简要总结

This prospective observational cohort study aims to evaluate the prognostic value of multimodal nutritional status and sarcopenia assessment in patients undergoing lung cancer surgery. Postoperative complications, mortality, and prolonged hospital stay remain major clinical concerns in thoracic surgery. Although malnutrition and sarcopenia are recognized as important determinants of surgical outcomes, their combined and multidimensional evaluation has not been sufficiently studied.

Adult patients undergoing anatomical lung resection for primary lung cancer will be included. Nutritional status will be assessed using serum biomarkers, inflammatory indices, and validated clinical nutritional scores. Sarcopenia will be evaluated using computed tomography-based muscle mass and density measurements, as well as ultrasonographic muscle thickness.

These parameters will be analyzed in relation to postoperative complications, intensive care unit (ICU) requirement, length of hospital stay, and mortality. Multivariable analyses will be performed to identify independent predictors, and a combined risk stratification model will be developed.

This study aims to improve preoperative risk assessment and to support personalized perioperative management strategies, including identification of patients who may benefit from targeted nutritional optimization and prehabilitation.

详细描述

This prospective, single-center observational cohort study will be conducted at Ondokuz Mayis University, Department of Thoracic Surgery. The study aims to investigate the combined prognostic impact of nutritional status and sarcopenia on postoperative outcomes in patients undergoing lung cancer surgery.

Postoperative morbidity and mortality remain significant concerns following lung cancer surgery. Current risk stratification approaches mainly focus on age, comorbidities, and pulmonary function, while modifiable biological factors such as nutritional status and sarcopenia are not systematically integrated into routine assessment.

In this study, nutritional status will be evaluated using serum biomarkers (including albumin and inflammatory markers), inflammatory indices such as CRP/albumin ratio, and validated clinical nutritional scores (including NRS-2002, CONUT, PNI, and NRI). Dietitian-based assessments will include bioimpedance analysis, handgrip strength, and functional performance tests.

Sarcopenia will be assessed using preoperative computed tomography (CT) by measuring skeletal muscle area, muscle density, and pectoralis muscle index. Ultrasonographic measurements of pectoral muscle thickness will also be obtained. Sarcopenia will be defined according to established international consensus criteria.

Postoperative outcomes including complications, intensive care unit requirement, length of hospital stay, and short-term mortality will be recorded. Complications will be classified using a standardized severity grading system.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years
  • Patients undergoing anatomical lung resection (lobectomy or segmentectomy) for primary lung cancer
  • Availability of preoperative thoracic computed tomography (CT) within 30 days before surgery
  • Completion of preoperative nutritional assessment and ultrasonographic muscle measurements
  • Ability to provide written informed consent

排除标准

  • Receipt of neoadjuvant chemotherapy, immunotherapy, or radiotherapy
  • Emergency surgery
  • Pneumonectomy
  • Combined resection of another organ during the same procedure
  • Inadequate or non-evaluable imaging or measurement data
  • Immunosuppressive therapy or presence of advanced/metastatic disease
  • Significant thoracic deformity or prior conditions interfering with muscle measurements
  • Refusal or inability to provide informed consent

结局指标

主要结局

Postoperative complications (30-day, Clavien-Dindo classification)

时间窗: Within 30 days after surgery

Occurrence of postoperative complications within 30 days after surgery, classified according to the Clavien-Dindo classification system. Major complications are defined as Grade III or higher. This outcome will be analyzed as both overall complication rate and major complication rate.

次要结局

  • Length of hospital stay(Postoperative period (up to 30 days))

研究者

发起方
Ondokuz Mayıs University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Caner İşevi, MD

Principal Investigator

Ondokuz Mayıs University

研究点 (1)

Loading locations...

相似试验